Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenetic Biosciences (XBIO) Change in Cash (2023 - 2025)

Xenetic Biosciences' Change in Cash history spans 7 years, with the latest figure at $3.8 million for Q4 2025.

  • For Q4 2025, Change in Cash rose 658.17% year-over-year to $3.8 million; the TTM value through Dec 2025 reached $1.7 million, up 160.98%, while the annual FY2025 figure was $1.7 million, 160.98% up from the prior year.
  • Change in Cash reached $3.8 million in Q4 2025 per XBIO's latest filing, up from -$658247.0 in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $3.8 million in Q4 2025 to a low of -$1.3 million in Q2 2023.
  • Average Change in Cash over 3 years is -$434469.4, with a median of -$733509.5 recorded in 2023.
  • The largest YoY upside for Change in Cash was 658.17% in 2025 against a maximum downside of 43.4% in 2025.
  • A 3-year view of Change in Cash shows it stood at -$793027.0 in 2023, then grew by 15.01% to -$673992.0 in 2024, then surged by 658.17% to $3.8 million in 2025.
  • Per Business Quant, the three most recent readings for XBIO's Change in Cash are $3.8 million (Q4 2025), -$658247.0 (Q3 2025), and -$383830.0 (Q2 2025).